Romanth Waghmarae

Romanth Waghmarae practices at WNY Medical Management, LLC in Buffalo, New York.

Romanth Waghmarae's NPI, 1174530299, was assigned on August 2, 2006. Romanth Waghmarae graduated from University of the Witwatersrand in 1981. Romanth Waghmarae holds New York license 171388.

Romanth Waghmarae's primary practice is WNY Medical Management, LLC, at 3112 Sheridan Dr, Buffalo, NY 14226 in Erie County. The practice phone is (716) 931-4963.

Romanth Waghmarae's primary practice is WNY Medical Management, LLC in Buffalo, New York. The medical group on file is Parkside Medical Anesthesia Associates. Dmand AI also links Romanth Waghmarae to 4 more medical groups, 1 physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Romanth Waghmarae practices, 2 sites in all. Vendor and product names are available with a free account.

Pain medicine is Romanth Waghmarae's primary specialty in the NPI Registry, under taxonomy code 207LP2900X. Romanth Waghmarae is licensed in New York.

CMS data shows 626 Medicare services from Romanth Waghmarae across 12 procedure codes in 2024, for 408 Medicare patients. Medicare paid $44,384 for them.

CMS counts 408 Medicare patients who saw Romanth Waghmarae in 2024. The largest group is 65 to 74, with 173 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 21% are also on Medicaid. Their average risk score is 1.38, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Romanth Waghmarae's median patient age at 64, with 62% women.

In 2024, Romanth Waghmarae wrote 2,159 Medicare Part D claims for 294 patients. 82% of them were for generic drugs. CMS names the drug for 2,014 of them, across 32 drugs with 11 or more claims each, at $273,880 in total drug cost. In 2023, CMS named 2,106 claims across 33 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Romanth Waghmarae for performance year 2024, reported as part of a group. Romanth Waghmarae accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Laminectomy or laminotomy (partial removal of spine bones): 1 to 10 procedures (CMS shows small counts as a range)

Spinal fusion: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links Romanth Waghmarae to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Chronic Pain and Pain. Open Payments lists research payments to Romanth Waghmarae that name 1 trial.

CMS Open Payments shows 2,655 general payments to Romanth Waghmarae from 91 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 66% of the total. Boston Scientific Corporation paid the most, $165,145. It also lists 5 research payments totaling $10,647 from 2018 to 2023, naming 1 clinical trial.

Romanth Waghmarae graduated from University of the Witwatersrand in 1981.